Press Releases

SHENZHEN, China, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, ("Huize", the "Company") (NASDAQ:HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced that it plans to release its first half 2026 unaudited financial results before the U.S. market opens on Thursday, August 20, 2026. The Company’s management team will hold an earnings conference call at 8:00 A.M. Eastern Daylight Time on Thursday, August 20, 2026 (8:00 P.M. Beijing/Hong Kong Time on Thursday, August 20, 2026). Details of the conference call are as follows: Event Title: Huize

-- Second Quarter Revenues of RMB 1,440.4 million, up 14.7% year over year -- Second Quarter Net Loss of RMB 102.2 million, compared with Net Income of RMB 5.9 million in the same period of 2025 BEIJING, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU" or the "Company") (NASDAQ:NIU), the world’s leading provider of smart urban mobility solutions, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenues were RMB 1,440.4 million, an increase of 14.7% year over yearGross margin was 16.0%, compared with 20.1% in the second quarter of 2025Net loss was RMB 102.2 million, compared with net income of

FARO, Portugal and HOLMDEL, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced that, together with its strategic Portuguese partner Visualforma, it has been awarded a new contract to strengthen digital identity security for a Portuguese national security agency. The award is a significant expansion of BIO-key’s and Visualforma’s long-standing collaboration within the Portuguese public sector. Following successful deployments across government organizations and municipalities, it now extends into one of the country’s most security-sensitive envi

Transaction will enhance Oculis’ strategic flexibility and ownership of Privosegtor while driving long-term value creationTransaction consideration includes $3.8 million up-front cash payment at closing and up to 2,050,000 Oculis ordinary shares subject to lockup release over a period of up to 2 years, or vesting upon achievement of development and regulatory milestonesPrivosegtor, a neuroprotective drug candidate, is currently being investigated in registrational trials with initial indications of optic neuropathies and acute multiple sclerosis (MS) relapses Investigational New Drug (IND) submission being prepared for Q4 2026 ZUG, Switzerland and BARCELONA, Spain, August 10, 2026 -- Oculis

Consumers can pay, send and spend in złoty, with a debit card in their pockets or on their phones Paysafe (NYSE:PSFE), PaysafeWallet has arrived in Poland and it’s built for a new generation. Polish consumers can now access a digital wallet giving them their own personal debit card, on their phone, built for the way they live, spend and have fun today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260810874560/en/PaysafeWallet is now available in Poland. Poland has strong adoption of PaysafeCard, and this builds on that foundation. PaysafeWallet extends what customers already trust into a broader, more complete wallet experie

TAIPEI, Aug. 10, 2026 /PRNewswire/ -- ASE Technology Holding Co., Ltd. (NYSE:ASX, IEX:3711, ", ASEH", or the ", Company", )), announces its unaudited consolidated net revenues for July 2026. CONSOLIDATED NET REVENUES (UNAUDITED)JulJunJulSequentialYoY(NT$ Million)202620262025ChangeChangeNet Revenues73,78465,78351,542+12.2 %+43.2 %JulJunJulSequentialYoY(US$ Million)202620262025ChangeChangeNet Revenues2,3092,0921,769+10.4 %+30.6 %Net revenues for ATM assembly, testing and material business are as follows:ATM NET REVENUES (UNAUDITED)JulJunJulSequentialYoY(NT$ Million)202620262025ChangeChangeNet Revenues47,52443,48531,783+9.3 %+49.5 %JulJunJulSequentialYoY(US$ Million)202620262025ChangeChangeNet

STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (PARIS:IPH) (NASDAQ:IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma (CTCL), a key step toward filing for accelerated approval of lacutamab in Sézary syndrome, a subtype of CTCL. Under the agreement, Innate will conduct the TELLOMAK-3 Phase 3 confirmatory trial in cutaneous T-cell lymphoma, supporting a planned accelerated approval filing in Sézary syndrome. The planned TELLOMAK-3 study will subsequently support applications for full approvals in k

Innate to advance lacutamab towards TELLOMAK-3 Phase 3 following the partnership with Sobi, a key step toward the filing for accelerated approval in Sézary syndrome Markus Jensen appointed Chief Medical Officer, bringing leadership continuity to execute TELLOMAK-3 and to prepare for upcoming IPH4502 development milestones Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that, subject to the closing of its strategic partnership with Sobi, it plans to initiate the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma (CTCL). Innate also announced the appointment of Markus Jensen as Chief Medical Officer a

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") and Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T-cell lymphoma (CTCL), a key step toward filing for accelerated approval of lacutamab in Sézary syndrome, a subtype of CTCL. Under the agreement, Innate will conduct the TELLOMAK-3 Phase 3 confirmatory trial in cutaneous T-cell lymphoma, supporting a planned accelerated approval filing in Sézary syndrome. The planned TELLOMAK-3 study will subsequently support applications for full approvals in key jurisdictions in

Next-Generation PerformaShape™ Technology Significantly Improves SSD QoS for Agentic AI Silicon Motion Technology Corporation (NASDAQ:SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today unveiled its new MonTitan™ SSD Reference Design Kit (RDK), featuring the company’s next-generation patented PerformaShape™ technology. Designed for Agentic AI infrastructure, the platform enables enterprise SSDs to serve as a persistent memory layer supporting KV cache offload and autonomous AI agents, while delivering predictable QoS, sustained performance, and optimized endurance for dynamic, always-on Agentic AI workloads. This press release f

Seadrill Limited ("Seadrill" or the "Company") (NYSE:SDRL) today announced its second quarter 2026 results. Highlights Secured contract awards and extensions in the U.S. Gulf and Malaysia, adding approximately $200 million to Contract Backlog(1) subsequent to the May fleet status report. Extended the Company's share repurchase program through December 31, 2026, and repurchased approximately $20 million of shares in the second quarter. Refinanced prior senior notes due in 2030, extending maturity into 2034 and increased the revolving credit facility to $300 million from $225 million, extending maturity to 2031. Reported net income of $29 million and Adjusted EBITDA(2) of $144 m

BEIJING, Aug 10, 2026 /PRNewswire/ -- Sohu.com Limited (NASDAQ:SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today reported unaudited financial results for the second quarter ended June 30, 2026. Second Quarter Highlights[1]Total revenues were US$136 million, up 7% year-over-year and down 4% quarter-over-quarter.Marketing services revenues were US$15 million, down 3% year-over-year and up 21% quarter-over-quarter.Online game revenues were US$116 million, up 10% year-over-year and down 7% quarter-over-quarter.After giving effect to reversal of a tax expense of approximately US$

On August 7, FF officially received notice from Nasdaq that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and the related compliance matter has now been formally closed. FF makes two technological breakthroughs for its FF EAI Robotics, including the launch of Version 1.0 of FF’s self-developed Universal Beyond-Line-of-Sight (BLOS) Teleoperation and Multi-Robot Control Platform along with making a series of practical upgrades to FF EAI Robotics’ security and inspection solutions. Two upcoming "Built in USA" Upstream & Downstream Partner Recruitment Conferences are planned; the first on August 26, will focus on downstre

CASTLE ROCK, Colo., Aug. 09, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a leader in vertically integrated digital infrastructure specializing in the development of large-scale data centers and Bitcoin mining applications, announced today that it has rescheduled the second quarter 2026 earnings conference call for Monday, August 10, 2026, at 4:30 P.M. EST. This conference call will be available through a webcast. Please use this link here to register. Participants who choose to dial into the call in the United States or internationally to ask questions, please use this toll-free number: +1 (800) 715-9871 or toll number: +1 (646) 307-1963. For bot

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial Officer, on August 12, 2026, at 4:00 p.m. Pacific Time (August 13, 2026, at 9:00 a.m. Australian Eastern Standard Time). The webinar presentation will cover financial and business results from AVITA Medical’s recent second-quarter 2026 earnings webcast and will conclude with a Q&A session. Participants are invited to sub

Silence Therapeutics plc, (NASDAQ:SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced a conference call and webcast to discuss topline results from the Phase 2 SANRECO trial of divesiran in polycythemia vera (PV) scheduled for tomorrow, Monday, August 10, 2026 at 8:00 a.m. EDT. Investor Webcast & Conference Call Information Conference call link: https://register-conf.media-server.com/register/BI4a60039edc0640388f2ba0a6aab560e2 Webcast link: https://edge.media-server.com/mmc/p/q6mmpxd5 A replay of the webcast will be available on the Investors section of the Silence website at www.silence-therapeutics.com/events. About Sil

Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 56.5% to a quarterly record of $32.4 million in the second quarter of 2026 from $20.7 million in the second quarter of 2025; Annual Recurring Revenue(4) (ARR) increased from $53.5 million at June 30, 2025 to $105.5 million at June 30, 2026 and sequentially increased from $96.9 million at March 31, 2026Total Company Adjusted EBITDA(1) was a quarterly record of $99.7 million in the second quarter of 2026 as compared with $81.2 million in the se

NAPLES, Fla., Aug. 9, 2026 /PRNewswire/ -- Beasley Broadcast Group, Inc. (NASDAQ:BBGI) (the "Company"), a multi-platform media company, announced today that it will postpone the reporting of its Q2 2026 financial results and the date of the conference call and webcast to allow additional time to finalize the tax accounting treatment relating to the refinancing and debt restructuring that the Company completed during Q2 2026. The Company will make a further announcement in a subsequent press release to reschedule the date and time of the conference call and webcast to review its Q2 2026 financial results, which it expects will b

TORONTO, Aug. 9, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ:TZOO), the club for travel enthusiasts, announces four of many new Club Offers for Club Members in Canada. Rigorously vetted and negotiated for us travel enthusiasts:$799—PORTUGAL COASTAL GETAWAY WITH FLIGHTSThe Algarve's golden beaches and charming villages await with this five-night holiday. (Longer trips are also available.) Stay near the ocean and scenic hiking trails in an apartment-style hotel near Carvoeiro. Includes flights from Toronto, taxes and fees.  61% OFF—MALDIVES ALL-INCLUSIVE OVERWATER VILLA FOR 2Thanks to our longstanding relationship with this private i

NEW YORK, Aug. 9, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ:TZOO), the club for travel enthusiasts, announces six of many new Club Offers for Club Members in the U.S. Rigorously vetted and negotiated for us travel enthusiasts:$1099—MAUI HYATT VACATION WITH FLIGHTSThis Hyatt resort is located on top-rated Ka'anapali Beach. Go for four nights (or longer) this fall. Roundtrip flights plus taxes and fees are included. $99—HOTEL STAYS NATIONWIDE WITH NO RESORT FEESWe've negotiated savings of up to 70% off regular rates at well-reviewed hotels in cities across the country, including San Francisco, Chicago, New Orleans, Palm Springs and